Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension
Reduced expression and/or activity of Kv1.5 channels (encoded byKCNA5) is a common hallmark in human or experimentalpulmonary arterial hypertension (PAH). Likewise, genetic variantsinKCNA5have been found in patients with PAH, but theirfunctional consequences and potential impact on the disease arela...
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2023 |
| País: | España |
| Institución: | Universidad Complutense de Madrid (UCM) |
| Repositorio: | Docta Complutense |
| Idioma: | inglés |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/92546 |
| Acceso en línea: | https://hdl.handle.net/20.500.14352/92546 |
| Access Level: | acceso abierto |
| Palabra clave: | 615.01/.03 KCNA5 variants Kv1.5 Ion channels Potassium channels Pulmonary hypertension Farmacología (Medicina) 2411.03 Fisiología Cardiovascular |
| id |
ES_414ca75d46552fe3f8ced025dd8fb5e4 |
|---|---|
| oai_identifier_str |
oai:docta.ucm.es:20.500.14352/92546 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial HypertensionVera Zambrano, AlbaMorales Cano, DanielVillegas Esguevillas, MartaCruz Utrilla, AlejandroFernández Malavé, Edgar GonzaloEscribano Subías, María PilarPérez Vizcaíno, FranciscoCogolludo Torralba, Ángel Luis615.01/.03KCNA5 variantsKv1.5Ion channelsPotassium channelsPulmonary hypertensionFarmacología (Medicina)2411.03 Fisiología CardiovascularReduced expression and/or activity of Kv1.5 channels (encoded byKCNA5) is a common hallmark in human or experimentalpulmonary arterial hypertension (PAH). Likewise, genetic variantsinKCNA5have been found in patients with PAH, but theirfunctional consequences and potential impact on the disease arelargely unknown. Herein, this study aimed to characterize thefunctional consequences of sevenKCNA5variants found in a cohortof patients with PAH. Potassium currents were recorded by patch-clamp technique in HEK293 cells transfected with wild-type ormutant Kv1.5 cDNA. Flow cytometry, Western blot, and confocalmicroscopy techniques were used for measuring protein expressionand cell apoptosis in HEK293 and human pulmonary artery smoothmuscle cells.KCNA5variants (namely, Arg184Pro and Gly384Arg)found in patients with PAH resulted in a clear loss of potassiumchannel function as assessed by electrophysiological and molecular modeling analyses. The Arg184Pro variant also resulted in apronounced reduction of Kv1.5 expression. Transfection withArg184Pro or Gly384Arg variants decreased apoptosis ofhuman pulmonary artery smooth muscle cells compared withthe wild-type cells, demonstrating thatKCNA5dysfunction inboth variants affects cell viability. Thus, in addition toaffecting channel activity, both variants were associated withimpaired apoptosis, a crucial process linked to the disease. Theestimated prevalence of dysfunctionalKCNA5variants in thePAH population analyzed was around 1%. The data indicatethat someKCNA5variants found in patients with PAH havecritical consequences for channel function, supporting the ideathatKCNA5pathogenic variants may be a causative orcontributing factor for PAH.American Thoracic SocietyUniversidad Complutense de Madrid20232023-03-1420232023-03-14journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/92546reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/925462026-06-02T12:44:21Z |
| dc.title.none.fl_str_mv |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension |
| title |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension |
| spellingShingle |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension Vera Zambrano, Alba 615.01/.03 KCNA5 variants Kv1.5 Ion channels Potassium channels Pulmonary hypertension Farmacología (Medicina) 2411.03 Fisiología Cardiovascular |
| title_short |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension |
| title_full |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension |
| title_fullStr |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension |
| title_full_unstemmed |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension |
| title_sort |
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension |
| dc.creator.none.fl_str_mv |
Vera Zambrano, Alba Morales Cano, Daniel Villegas Esguevillas, Marta Cruz Utrilla, Alejandro Fernández Malavé, Edgar Gonzalo Escribano Subías, María Pilar Pérez Vizcaíno, Francisco Cogolludo Torralba, Ángel Luis |
| author |
Vera Zambrano, Alba |
| author_facet |
Vera Zambrano, Alba Morales Cano, Daniel Villegas Esguevillas, Marta Cruz Utrilla, Alejandro Fernández Malavé, Edgar Gonzalo Escribano Subías, María Pilar Pérez Vizcaíno, Francisco Cogolludo Torralba, Ángel Luis |
| author_role |
author |
| author2 |
Morales Cano, Daniel Villegas Esguevillas, Marta Cruz Utrilla, Alejandro Fernández Malavé, Edgar Gonzalo Escribano Subías, María Pilar Pérez Vizcaíno, Francisco Cogolludo Torralba, Ángel Luis |
| author2_role |
author author author author author author author |
| dc.contributor.none.fl_str_mv |
Universidad Complutense de Madrid |
| dc.subject.none.fl_str_mv |
615.01/.03 KCNA5 variants Kv1.5 Ion channels Potassium channels Pulmonary hypertension Farmacología (Medicina) 2411.03 Fisiología Cardiovascular |
| topic |
615.01/.03 KCNA5 variants Kv1.5 Ion channels Potassium channels Pulmonary hypertension Farmacología (Medicina) 2411.03 Fisiología Cardiovascular |
| description |
Reduced expression and/or activity of Kv1.5 channels (encoded byKCNA5) is a common hallmark in human or experimentalpulmonary arterial hypertension (PAH). Likewise, genetic variantsinKCNA5have been found in patients with PAH, but theirfunctional consequences and potential impact on the disease arelargely unknown. Herein, this study aimed to characterize thefunctional consequences of sevenKCNA5variants found in a cohortof patients with PAH. Potassium currents were recorded by patch-clamp technique in HEK293 cells transfected with wild-type ormutant Kv1.5 cDNA. Flow cytometry, Western blot, and confocalmicroscopy techniques were used for measuring protein expressionand cell apoptosis in HEK293 and human pulmonary artery smoothmuscle cells.KCNA5variants (namely, Arg184Pro and Gly384Arg)found in patients with PAH resulted in a clear loss of potassiumchannel function as assessed by electrophysiological and molecular modeling analyses. The Arg184Pro variant also resulted in apronounced reduction of Kv1.5 expression. Transfection withArg184Pro or Gly384Arg variants decreased apoptosis ofhuman pulmonary artery smooth muscle cells compared withthe wild-type cells, demonstrating thatKCNA5dysfunction inboth variants affects cell viability. Thus, in addition toaffecting channel activity, both variants were associated withimpaired apoptosis, a crucial process linked to the disease. Theestimated prevalence of dysfunctionalKCNA5variants in thePAH population analyzed was around 1%. The data indicatethat someKCNA5variants found in patients with PAH havecritical consequences for channel function, supporting the ideathatKCNA5pathogenic variants may be a causative orcontributing factor for PAH. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023 2023-03-14 2023 2023-03-14 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/20.500.14352/92546 |
| url |
https://hdl.handle.net/20.500.14352/92546 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
American Thoracic Society |
| publisher.none.fl_str_mv |
American Thoracic Society |
| dc.source.none.fl_str_mv |
reponame:Docta Complutense instname:Universidad Complutense de Madrid (UCM) |
| instname_str |
Universidad Complutense de Madrid (UCM) |
| reponame_str |
Docta Complutense |
| collection |
Docta Complutense |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869406837028159488 |
| score |
15.300724 |